Top Sell
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
---|---|---|---|---|---|---|---|
Biogen Inc. | 55 | 2 | 4 | 0 | €169.15 | €276.44 | 63.432% |
Mirati Therapeutics Inc. | 1 | 10 | 0 | 0 | €53.84 | €78.43 | 45.666% |
Intellia Therapeutics Inc | 16 | 1 | 2 | 0 | €16.39 | €58.89 | 259.312% |
Larimar Therapeutics Inc. | 2 | 3 | 0 | 0 | €5.80 | €58.50 | 908.621% |
Ionis Pharmaceuticals Inc. | 27 | 6 | 1 | 0 | €34.53 | €56.83 | 64.588% |
Arrowhead Pharmaceuticals Inc. | 21 | 1 | 2 | 0 | €17.07 | €54.83 | 221.195% |
Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.05 | €50.00 | 4652.852% |
Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.50 | €50.00 | 185.714% |
Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €37.20 | €50.00 | 34.409% |
Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
Rocket Pharmaceuticals Inc | 3 | 1 | 1 | 0 | ? | €26.50 | 77.198% |
Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.31 | €23.82 | 277.405% |
Moleculin Biotech Inc | 3 | 26 | 0 | 3 | €0.41 | €18.42 | 4393.659% |
Ironwood Pharmaceuticals | 9 | 1 | 0 | 0 | €3.74 | €18.27 | 388.503% |
Uniqure B.V. | 1 | 2 | 0 | 0 | €5.15 | €11.00 | 113.675% |
Inotiv Inc. | 4 | 1 | 1 | 0 | €1.71 | €9.93 | 480.602% |
Glycomimetics Inc. | 3 | 9 | 0 | 2 | €0.14 | €9.13 | 6278.911% |
Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €2.90 | €7.31 | 151.996% |
Trevena Inc. | 2 | 26 | 0 | 3 | €0.15 | €6.48 | 4136.601% |
Inventiva SA | 1 | 1 | 0 | 1 | €1.63 | €6.00 | 267.197% |
Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.51 | €5.47 | 963.403% |
Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.73 | €4.99 | 588.607% |
Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.25 | €4.61 | 1763.813% |